Stock DRREDDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01023

Market Closed - Bombay S.E.
Other stock markets
 06:00:47 2024-05-14 am EDT 		5-day change 1st Jan Change
5,871 INR -0.80% Intraday chart for Dr. Reddy's Laboratories Limited -6.82% +1.26%
04:57pm Asian Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
May. 13 Asian Equities Traded in the US as American Depositary Receipts Begin Week Higher MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Asian Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Begin Week Higher
MT
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week 1% Lower
MT
Asian Equities Traded in the US as American Depositary Receipts Trend Lower Thursday
MT
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
RE
Asian Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Wednesday Trading
MT
Indian Equities Settle Flat on Wednesday, Dragged by Banks, FMCG Stocks
MT
Jefferies Adjusts Dr. Reddy’s Laboratories’ Price Target to INR5,010 From INR5,040, Keeps at Underperform
MT
Dr. Reddy's Consolidated Net Profit Jumps in Fiscal Q4; Shares Slide 3%
MT
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading
MT
Dr. Reddy’s Q4 & Full Year FY24 Financial Results
BU
Transcript : Dr. Reddy's Laboratories Limited, Q4 2024 Earnings Call, May 07, 2024
Dr. Reddy's Laboratories Fiscal Q4 Earnings, Revenue Gain
MT
Dr Reddy Laboratories : Q4FY24 Press PPT
PU
Doctor Reddy's: Fiscal Q4 Earnings Snapshot
AQ
India's Dr Reddy's beats Q4 profit estimates
RE
Dr. Reddy's Laboratories Limited Announces Cessation of Parag Agarwal as Member of Management Council
CI
Dr. Reddy's Laboratories Limited Announces Chief Financial Officer Changes
CI
Dr. Reddy's Laboratories Limited Recommends Final Dividend for the Financial Year 2023-2024
CI
Dr. Reddy's Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. News Dr. Reddy's Laboratories Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW